Shareholders of Hungarian drug maker Egis approved the board's proposal that Egis pay a dividend of HUF 120-per-share from after-tax profits of HUF 18.73 billion posted in the company's 2010 business year ending on September 30 at the company's annual general meeting on Wednesday AGM.
The 2010 dividend is unchanged from that the company has paid over the past few years.
Egis will place the HUF 17.79 billion remaining from the company's 2010 profits following the payment of the dividend in profit reserves.
Egis met its targets on strategic markets and tight cost management counterbalanced a temporary drop of sales on other markets, deputy CEO László Marossfy said. Marossfy will leave his post as of the end of January. (MTI-Econews)